Get started
Author

Marika Nestor

Observed names: M. Nestor, MARIKA V. NESTOR, Marika V. Nestor, Nestor, Marika
ORCID: 0000-0003-4662-3142
Observed ORCID: 0000-0003-4662-3142
OpenAlex ID: A5060280323
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
2014 · Sara Häggblad Sahlberg, Diana Spiegelberg, et al. · PLoS ONE · 218
PDF
Targeted therapy in head and neck cancer
2012 · S. K. Kundu, M. Nestor · Tumor Biology · 96
Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells
2016 · Sara Häggblad Sahlberg, Anja C. Mortensen, et al. · International Journal of Oncology · 86
PDF
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo
2021 · Fernanda Andrade, Diana Rafael, et al. · Journal of Controlled Release · 71
A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
2020 · Patrik Johansson, Cecilia Krona, et al. · Cell Reports · 71
PDF
Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6
2018 · Patrick J. Kennedy, Flavia Sousa, et al. · Acta Biomaterialia · 48
Complementarity-determining region clustering may cause CAR-T cell dysfunction
2023 · Tina Sarén, Giulia Saronio, et al. · Nature Communications · 44
PDF
Adduct formation in electrospray ionisation-mass spectrometry with hydrophilic interaction liquid chromatography is strongly affected by the inorganic ion concentration of the samples
2019 · Ida Erngren, Jakob Haglöf, et al. · Journal of Chromatography A · 42
The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells
2015 · Diana Spiegelberg, Adrian Dascalu, et al. · Oncotarget · 41
The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach
2020 · Diana Spiegelberg, Andris Abramenkovs, et al. · Scientific Reports · 40
PDF
The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors
2018 · Diana Spiegelberg, Anja C. Mortensen, et al. · Cancer Research · 40
The radiosensitizer Onalespib increases complete remission in 177Lu-DOTATATE-treated mice bearing neuroendocrine tumor xenografts
2020 · Sara Lundsten, Diana Spiegelberg, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 38
PDF
Characterization of CD44 variant expression in head and neck squamous cell carcinomas
2013 · D. Spiegelberg, G. Kuku, et al. · Tumor Biology · 32
PDF
The HSP90 inhibitor onalespib potentiates 177Lu‑DOTATATE therapy in neuroendocrine tumor cells
2019 · Sara Lundsten, Diana Spiegelberg, et al. · International Journal of Oncology · 31
PDF
Selection and in vitro characterization of human CD44v6‐binding antibody fragments
2012 · Johan Nilvebrant, Gamze Kuku, et al. · Biotechnology and Applied Biochemistry · 31
Analysis of radiation effects in two irradiated tumor spheroid models
2017 · Afkar Al‑Ramadan, Anja Mortensen, et al. · Oncology Letters · 30
PDF
Exploring Radiation Response in Two Head and Neck Squamous Carcinoma Cell Lines Through Metabolic Profiling
2019 · Eva Lindell Jonsson, Ida Erngren, et al. · Frontiers in Oncology · 29
PDF
Tumor-Cell Targeted Epidermal Growth Factor Liposomes Loaded with Boronated Acridine: Uptake and Processing
2003 · Erika Bohl Kullberg, Marika Nestor, et al. · Pharmaceutical Research · 28
Molecular imaging of EGFR and CD44v6 for prediction and response monitoring of HSP90 inhibition in an in vivo squamous cell carcinoma model
2015 · Diana Spiegelberg, Anja C. Mortensen, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 27
PDF
Bivalent binding on cells varies between anti-CD20 antibodies and is dose-dependent
2020 · Sina Bondza, Toine ten Broeke, et al. · mAbs · 26
Targeting CD44v6 Expressed in Head and Neck Squamous Cell Carcinoma: Preclinical Characterization of an 111In-Labeled Monoclonal Antibody
2008 · Karl Sandström, Marika Nestor, et al. · Tumor Biology · 26
In vitro evaluation of the astatinated chimeric monoclonal antibody U36, a potential candidate for treatment of head and neck squamous cell carcinoma
2005 · M. Nestor, M. Persson, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 25
Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF
2010 · Heewa Kareem, Karl Sandström, et al. · Tumor Biology · 24
Method selectivity evaluation using the co-feature ratio in LC/MS metabolomics: Comparison of HILIC stationary phase performance for the analysis of plasma, urine and cell extracts
2018 · Albert Elmsjö, Jakob Haglöf, et al. · Journal of Chromatography A · 23
Characterization of 111In and 177Lu‐labeled antibodies binding to CD44v6 using a novel automated radioimmunoassay
2008 · Marika Nestor, Karl Andersson, et al. · Journal of Molecular Recognition · 23
Works count: 147
Citation count: 1,650
H-index: 23
I10-index: 48
Year
Topic
Type